CERO THERAPEUTICS HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 30 shares as of 2024-10-01, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-04-15
- 2024-10-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 30.00 shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period as first filed 34.55K shares.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 1.73K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period as first filed 34.55K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period as first filed |
|---|---|---|
| 2024-10-01 | 30.00 shares 10-K · filed 2026-04-15 | 34.55K shares 10-K · filed 2025-04-15 |
| 2024-09-30 | 1.73K shares 10-K · filed 2026-04-15 | 34.55K shares 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |